secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001193125-26-211946
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q1 revenue $55.9M (-6% YoY); net loss $192.4M on $197M goodwill impairment
--------------------------------------------------------------------------------

- Revenue of $55.9M, at top end of guidance, down 6% from $59.2M in Q1 2025.
- Net loss of $(192.4)M includes $197.2M goodwill impairment; adjusted net income rose to $8.5M from $7.0M.
- Adjusted EBITDA $15.3M (27% margin) vs $14.7M (25%) YoY; operating cash flow $11.6M, unlevered FCF $18.0M.
- Q2 2026 guidance: revenue $55-56M, adj. EBITDA $13.5-14.5M. Full-year: revenue $220-226M, adj. EBITDA $55-59M.
- Customer wins include a six-figure multi-year life sciences deal and Monocl expansion from a biopharma acquisition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526211946/0001193125-26-211946-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312526211946/dh-20260507.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-211946

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer